Eurosurveillance | Molecular epidemiology of hepatitis A outbreaks and sporadic cases, Latvia, 2017 to 2019

Background Hepatitis A is an acute infection of the liver caused by hepatitis A virus (HAV). Molecular detection and typing of the HAV VP1/P2A genomic region is used for genotyping and outbreak investigations. After a large hepatitis A outbreak in Latvia in 2007โ€“08, only sporadic cases were registered until 2017 when a rise in cases occurred. During 2017โ€“19, 179 laboratory-confirmed hepatitis A cases were notified in Latvia. Aim To investigate the observed increase in hepatitis A cases during 2017 and to determine whether these cases were linked to one another, to risk groups, or to other outbreaks. The majority of HAV samples (69.8%) were typed. Methods The VP1/P2A genomic region of HAV was amplified and sequenced for 125 case serum samples. Information about hepatitis-related symptoms, hospitalisation, vaccination, a possible source of infection and suspected countries of origin of the virus were analysed for sequenced cases. Results Most HAV strains were subgenotype IA (nโ€‰=โ€‰77), of which 41 were strains circulating among men who have sex with men (MSM) populations in Europe (VRD_521_2016 (nโ€‰=โ€‰32), RIVM-HAV16โ€“090 (nโ€‰=โ€‰7) or V16โ€“25801 (nโ€‰=โ€‰2)). Forty-four cases were subgenotype IB and four cases subgenotype IIIA. However, other clusters and sporadic cases were detected with or without identifying the epidemiological link. Conclusion This work represents molecular epidemiological data of hepatitis A cases in Latvia from 2017 to 2019. Molecular typing methods allow identification of clusters for public health needs and establishing links with other outbreaks, and to compare Latvian strains with reported strains from other countries.

Eurosurveillance | Molecular epidemiology of hepatitis A outbreaks and sporadic cases, Latvia, 2017 to 2019

Background Hepatitis A is an acute infection of the liver caused by hepatitis A virus (HAV). Molecular detection and typing of the HAV VP1/P2A genomic region is used for genotyping and outbreak investigations. After a large hepatitis A outbreak in Latvia in 2007โ€“08, only sporadic cases were registered until 2017 when a rise in cases occurred. During 2017โ€“19, 179 laboratory-confirmed hepatitis A cases were notified in Latvia. Aim To investigate the observed increase in hepatitis A cases during 2017 and to determine whether these cases were linked to one another, to risk groups, or to other outbreaks. The majority of HAV samples (69.8%) were typed. Methods The VP1/P2A genomic region of HAV was amplified and sequenced for 125 case serum samples. Information about hepatitis-related symptoms, hospitalisation, vaccination, a possible source of infection and suspected countries of origin of the virus were analysed for sequenced cases. Results Most HAV strains were subgenotype IA (nโ€‰=โ€‰77), of which 41 were strains circulating among men who have sex with men (MSM) populations in Europe (VRD_521_2016 (nโ€‰=โ€‰32), RIVM-HAV16โ€“090 (nโ€‰=โ€‰7) or V16โ€“25801 (nโ€‰=โ€‰2)). Forty-four cases were subgenotype IB and four cases subgenotype IIIA. However, other clusters and sporadic cases were detected with or without identifying the epidemiological link. Conclusion This work represents molecular epidemiological data of hepatitis A cases in Latvia from 2017 to 2019. Molecular typing methods allow identification of clusters for public health needs and establishing links with other outbreaks, and to compare Latvian strains with reported strains from other countries.

RT @ECDC_EU: On the occasion of #WorldHepatitisDay, we publish today two annual epidemiological reports on #hepatitisB and #hepatitisC using the 2020 data.

Find out more on our dedicated #WorldHepatitisDay2022 page here:
https://www.ecdc.europa.eu/en/news-events/world-hepatitis-day-2022

๐Ÿฆ๐Ÿ”—: https://nitter.eu/EMA_News/status/1552578941193519104

World Hepatitis Day 2022

World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.

European Centre for Disease Prevention and Control

RT @ECDC_EU: On the occasion of #WorldHepatitisDay, we publish today two annual epidemiological reports on #hepatitisB and #hepatitisC using the 2020 data.

Find out more on our dedicated #WorldHepatitisDay2022 page here:
https://www.ecdc.europa.eu/en/news-events/world-hepatitis-day-2022

๐Ÿฆ๐Ÿ”—: https://nitter.eu/EU_Health/status/1552579315509800960

World Hepatitis Day 2022

World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.

European Centre for Disease Prevention and Control

RT @ECDC_EU: On the occasion of #WorldHepatitisDay, we publish today two annual epidemiological reports on #hepatitisB and #hepatitisC using the 2020 data.

Find out more on our dedicated #WorldHepatitisDay2022 page here:
https://www.ecdc.europa.eu/en/news-events/world-hepatitis-day-2022

๐Ÿฆ๐Ÿ”—: https://nitter.eu/EU_ECHA/status/1552574919115956226

World Hepatitis Day 2022

World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.

European Centre for Disease Prevention and Control

On the occasion of #WorldHepatitisDay, we publish today two annual epidemiological reports on #hepatitisB and #hepatitisC using the 2020 data.

Find out more on our dedicated #WorldHepatitisDay2022 page here:
https://bit.ly/3zBkbfO

๐Ÿฆ๐Ÿ”—: https://nitter.eu/ECDC_EU/status/1552574794561896448

World Hepatitis Day 2022

World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.

European Centre for Disease Prevention and Control